Portfolio Rapha Capital Management

Poseida Therapeutics Appoints Kerry Ingalls as Chief Operating Officer

By Kevin SlawinOctober 10, 2019February 4th, 2021No Comments

Poseida Therapeutics, Inc.
Poseida Therapeutics Appoints Kerry Ingalls as Chief Operating Officer
October 10, 2019

Previous PostNexImmune Receives IND Clearance for Phase 1/2 trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome
Next PostRapha Capital Management Participates in Series B Financing for ControlRad, Inc. Led by Questa Capital

© 2024 Ponce Therapeutics. Privacy Policy | Terms & Conditions